Doximity Inc.
DOCS-
Doximity Inc. slumped 20.7% to $46.36 after the networking site healthcare professionals' outlook fell short of market expectations.
Revenue jumped to $138.29 million from $118.06 million, net income climbed to $62.46 million from $40.62 million, and diluted earnings per share rose to 31 cents from 20 cents a year ago.
The company guided first-quarter revenue to be between $139 million and $140 million, compared to $126.7 million a year earlier, and adjusted EBITDA between $71 million and $72 million, compared to $65.9 million in the same period of fiscal 2025.
For the full year, Doximity estimated revenue to be between $619 million and $631 million, compared to $570.4 million in 2025, and adjusted EBITDA between $333 million and $345 million, compared to $313.8 million a year ago.
May 16, 2025 -
Doximity increased 16% to $23.81 after the company reported better-than-expected quarterly results.
Revenue in the fiscal 2024 second quarter ending in September increased 11% to $113.6 million from $102.2 million, net income jumped to $30.6 million from $26.3 million, and diluted earnings per share rose to 15 cents from 12 cents a year ago.
The company anticipated revenue in the fiscal third quarter ending in December in the range of $127 million and $128 million and adjusted EBITDA between $61 million and $62 million.
The healthcare professional company updated its full-year guidance to between $460 million and $472 million and adjusted EBITDA to between $207 million and $219 million.
At the time of announcing previous quarterly results, the company had estimated annual revenue between $452 million and $468 million and EBITDA between $193 million and $209 million.
The company's board authorized $70 million of its own stock repurchases over the next year.
Nov 10, 2023 -
Doximity Inc declined 5.5% to $32.02 after the company reported mixed quarterly results in the fiscal fourth quarter ending in March.
Revenue in the quartet increased 18% to $111.0 million from $97.0 million and net income dropped to $30.7 million from $36.7 million and diluted earnings per share declined to 14 cents from 20 cents a year ago.
The company forecasted revenue in the fiscal first quarter ending in June between $106.5 million and $107.5 million and for the full-year between $500 million and $506 million.
The company forecasted adjusted EBITDA in the June quarter between $39 million and $40.0 million and for the fiscal year 2024 between $216 million and $222 million.
May 17, 2023 -
Doximity said revenue in the December quarter increased 18% to $115.3 million and net income fell to $33.5 million from $55.6 million and diluted EPS fell to 16 cents from 26 cents a year ago.
Feb 10, 2023
|
|
| |
|
| Trading Volume | 547,482 |
|
|
36.75 - 19.85 |
| Market Cap Full | $ 7.1B |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | -57% | 3.4% | -4% | -3.6% |
| Q2 | - | 117.8% | 5.4% | 5.1% |
| Q3 | - | 117.8% | 31.2% | -37.6% |
| Q4 | - | 117.8% | -8.1% | 32.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| 3.4 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -3.9 | 4.8 | -4.7 | -9.6 | 14.1 | 0.3 | 0.6 | 31.2 | - | - | - | 0.7 |
| 2023 | |||||||||||
| 5.1 | -4.7 | -3.8 | 13.6 | -16.5 | 10.9 | 5 | -33.2 | -11 | -3.8 | 13.7 | 20.6 |
| 2022 | |||||||||||
| -9.1 | 34.6 | -15.1 | -18.8 | -17.3 | -0.5 | 21.5 | -21 | -9.7 | -12.4 | 28.4 | -1.3 |
| 2021 | |||||||||||
| - | - | - | - | - | - | 8.5 | 45.8 | -10.4 | -15.7 | -4.4 | -24.6 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | 0.2 | 0.2 | 0.2 |
| Q2 | 0.1 | 0.1 | 0.1 |
| Q3 | 0.2 | 0.1 | 0.2 |
| Q4 | 0 | 0.2 | 0.3 |
| A | 0.43 | 0.5 | 0.7 |